Gary R. Fanger
- Molecular Biology top 5%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 2%
- Immunology top 5%
- Co-authors
- Gary L. JohnsonChristian WidmannBruce A. WodaZhong JiangMatthew JarpeKaren DresserPär GerwinsJiangchun Xu
- Topics
- Epigenetics and DNA Methylation (8 papers)Melanoma and MAPK Pathways (6 papers)Protein Kinase Regulation and GTPase Signaling (6 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Gary R. Fanger
54 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 2.5k
- Oncology 954
- Pulmonary and Respiratory Medicine 800
- Cancer Research 769
- Immunology 599
Countries citing papers authored by Gary R. Fanger
This map shows the geographic impact of Gary R. Fanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary R. Fanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary R. Fanger more than expected).
Fields of papers citing papers by Gary R. Fanger
This network shows the impact of papers produced by Gary R. Fanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary R. Fanger. The network helps show where Gary R. Fanger may publish in the future.
Co-authorship network of co-authors of Gary R. Fanger
This figure shows the co-authorship network connecting the top 25 collaborators of Gary R. Fanger. A scholar is included among the top collaborators of Gary R. Fanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary R. Fanger. Gary R. Fanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapybreakdown → | 241 |
| 3 | 8 | |
| 4 | 90 | |
| 5 | 76 | |
| 6 | 23 | |
| 7 | 23 | |
| 8 | 61 | |
| 9 | 11 | |
| 10 | 144 | |
| 11 | 29 | |
| 12 | 141 | |
| 13 | 27 | |
| 14 | 6 | |
| 15 | 32 | |
| 16 | 49 | |
| 17 | 133 | |
| 18 | 30 | |
| 19 | 265 | |
| 20 | 10 |
About Gary R. Fanger
Gary R. Fanger is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 55 papers that have together received 4.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), Melanoma and MAPK Pathways (6 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). The work is most often cited by research in Cancer Research (769 citations), Molecular Biology (2.5k citations) and Oncology (954 citations). Gary R. Fanger has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Gary L. Johnson, Christian Widmann, Bruce A. Woda, Zhong Jiang, Matthew Jarpe, Karen Dresser, Pär Gerwins, Jiangchun Xu, Bryan Oronsky and Kenneth L. Rock. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.